Research news

Research News

The latest funding round now brings MDFA’s commitment to macular disease research to $5.8 million across 35 projects since 2011.

MDFA showcases groundbreaking research projects in new impact report

Macular Disease Foundation Australia (MDFA) has launched its new Research Impact Report, which showcases the groundbreaking projects our organisation has funded to help reduce the impact of macular disease.

Could a new supplement help slow AMD?

A/Prof Gerald Liew’s second MDFA Research Grant is allowing him to investigate a potential sight-saving supplement to improve dysfunctional mitochondria and prevent age-related macular degeneration (AMD).

Research study measuring the impact of AMD on quality of life

If you have AMD, you could help this MDFA-funded study.

Potential treatment for atrophic AMD on the horizon

Results have now been presented at medical conferences in the USA.

Potential new treatment for dry AMD

Apellis announces initial results from two phase III studies in geographic atrophy.

Wellbeing and AMD

MDFA funded researcher Ms Diana Tang is rolling out the Movement, Interaction and Nutrition for Greater Lifestyles in the Elderly – or MINGLE – program.

Creating the perfect laboratory macula model

MDFA funded researcher, Dr Anai Gonzalez Cordero is creating an organoid – essentially a mini organ in a dish – with a macular structure.

MDFA awards $1 million to eight exciting research projects

MDFA has awarded more than $1 million in research funding to eight promising projects, in the search for a cure for macular diseases.

10 years of MDFA Research Grants

Celebrating the 10th anniversary of MDFA’s Research Grants Program, this free publication introduces you to the talented researchers your donations have funded since 2011.

Grant Family Fund bequest: Lasting legacy to ‘best mates’

Faye Grant included MDFA in her Will. Her bequest is now funding vital, innovative research into macular disease through the Grant Family Fund.

Scientists test potential drug developed in Australia

A new chemical compound could become a future tool against retinal vascular disease. The finding is the result of a pre-clinical study, led by UNSW researchers.

MDFA showcases groundbreaking research projects in new impact report

Macular Disease Foundation Australia welcomes Federal Government cost increase freeze on PBS medicines

Affording sight-saving treatments and support is a challenge faced by many people in the macular disease community.

MDFA’s first South Australian Peer Support group to launch in April

Connecting with other people who are going through similar health experiences can improve how you manage your own condition.

Social Impact Survey 2: What did your patients tell us?

Macular Disease Foundation Australia (MDFA) is committed to understanding the impact of macular disease on the lives and health of people who live with the condition. One of the ways we do this is through our Social Impact research.

Diabetic eye disease: Laying the foundations for new treatments

Professor Chandra Balaratnasingam’s MDFA-funded research is exploring the cellular changes that occur in diabetic macular ischaemia (DMI) to help develop a breakthrough therapy.

Improving the diagnosis of macular disease

Grant Family Fund support is allowing Dr Alexis Ceecee Britten-Jones to research a way to ensure people with rare inherited macular dystrophies receive the right treatment for them in future.

AI, NASA and dry AMD

Find out how the Grant Family Fund is helping Dr Xavier Hadoux use cutting-edge technology to detect the early signs of macular disease.

Could a new supplement help slow AMD?

2023 Research Grant Program recipients announced

MDFA is Australia’s largest source of research funding in the field of macular disease outside of government.

Research news

Research News

Most popular

Most recent

Follow us

Newsletter sign-up

Thank you.Your contact form has been successfully submitted.

Unfortunately there are no matches for your search.

Please try another search term.

Thank you for your order!

Your pack will be sent in the next two business days.

Your expression of interest in our research grants program has been submitted.

We will be in touch at the next stage of the process.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for subscribing to MDFA’s newsletter/s.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about MDFA’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about Macular Disease Foundation’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about Macular Disease Foundation’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about Macular Disease Foundation’s newsletters:

Thank you for registering for this event.

Let people know you're attending:

The is for health professionals only. Please enter your organisation and practitioner type to subscribe. If you are not a health professional, please untick this newsletter to continue.

Thank you.
Your contact form has been successfully submitted.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about MDFA’s newsletters:

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters: